...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

I bought 50,000 since Jan 01,,,between .12 and .14 USD,,,,worth the risk I figure,,,,,only because big pharma seem interested,,,,,,and all this USD shopping because the ZENE management team again refuse to put us on an exchange. Thats how much McCaffery and the BoD hate us all! 

Share
New Message
Please login to post a reply